Stock listing
NASDAQ:VOGX Vogenx Inc Stock
Home listing (NASDAQ) of Vogenx Inc
Follow Vogenx Inc into a list and get an email when it puts out news.
Share price · NASDAQ:VOGX
$11.87 USD -0.47 (-3.8%)
Close on Nov 20, 2026
- Day range
- $11.87 – $13.30 USDNov 20, 2026
- Volume
- 100,911 sharesNov 20, 2026
- Market cap
- $176.3M USDAt the close on Nov 20, 2026 · price × 14.86M shares outstanding
- Traded on an average day
- $3.30M USDMedian day 100,911 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VOGX · Home | $11.87 USD | -0.47 (-3.8%) | 100,911 | $13.30 | $13.30 | $11.87 | $12.34 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:VOGX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $11.87 | -0.47 | -3.8% | $13.30 | $13.30 | $11.87 | 100,911 | |
| $12.34 | -1.14 | -8.5% | $12.78 | $14.64 | $12.10 | 135,715 | |
| $13.48 | -0.90 | -6.3% | $14.71 | $14.71 | $13.04 | 95,014 | |
| $14.38 | -2.29 | -13.7% | $16.29 | $16.71 | $12.61 | 195,234 | |
| $16.67 | -2.48 | -13.0% | $18.22 | $18.75 | $16.67 | 94,241 | |
| $19.15 | -1.62 | -7.8% | $20.66 | $20.80 | $18.67 | 104,621 | |
| $20.77 | +1.51 | +7.8% | $19.81 | $21.48 | $17.65 | 128,035 | |
| $19.26 | +0.92 | +5.0% | $18.34 | $19.65 | $17.44 | 113,978 | |
| $18.34 | +0.89 | +5.1% | $17.34 | $18.81 | $16.67 | 217,860 | |
| $17.45 | -0.78 | -4.3% | $18.16 | $18.90 | $17.14 | 66,333 | |
| $18.23 | -1.50 | -7.6% | $19.23 | $19.87 | $17.70 | 76,734 | |
| $19.73 | -0.80 | -3.9% | $20.30 | $21.52 | $19.22 | 123,716 | |
| $20.53 | -0.21 | -1.0% | $21.95 | $21.95 | $19.48 | 94,168 | |
| $20.74 | +0.49 | +2.4% | $20.27 | $20.97 | $19.28 | 152,307 | |
| $20.25 | +0.33 | +1.7% | $19.63 | $20.74 | $19.24 | 45,083 | |
| $19.92 | +1.00 | +5.3% | $19.40 | $21.96 | $19.25 | 75,375 | |
| $18.92 | -0.24 | -1.3% | $18.16 | $19.77 | $17.97 | 117,648 | |
| $19.16 | +1.82 | +10.5% | $17.18 | $20.76 | $17.18 | 75,126 | |
| $17.34 | -0.11 | -0.6% | $16.12 | $17.63 | $15.01 | 105,985 | |
| $17.45 | -1.63 | -8.5% | $19.29 | $19.76 | $16.93 | 64,500 | |
| $19.08 | -1.31 | -6.4% | $20.99 | $20.99 | $17.55 | 91,000 | |
| $20.39 | +1.64 | +8.7% | $18.98 | $22.24 | $18.98 | 84,300 | |
| $18.75 | +2.83 | +17.8% | $15.84 | $19.68 | $15.68 | 71,000 | |
| $15.92 | +1.39 | +9.6% | $14.53 | $16.89 | $14.53 | 86,900 | |
| $14.53 | -1.52 | -9.5% | $15.88 | $16.01 | $14.25 | 84,600 | |
| $16.05 | -0.05 | -0.3% | $16.07 | $17.82 | $15.61 | 186,600 | |
| $16.10 | -0.66 | -3.9% | $16.97 | $18.05 | $15.76 | 94,200 | |
| $16.76 | -0.38 | -2.2% | $17.05 | $17.09 | $15.25 | 98,700 | |
| $17.14 | -0.42 | -2.4% | $18.12 | $18.12 | $16.59 | 87,700 | |
| $17.56 | +0.07 | +0.4% | $17.29 | $19.17 | $17.05 | 77,200 | |
| $17.49 | +1.33 | +8.2% | $16.20 | $18.49 | $14.56 | 142,500 | |
| $16.16 | -0.23 | -1.4% | $16.22 | $16.80 | $14.80 | 237,900 | |
| $16.39 | -0.76 | -4.4% | $17.10 | $17.10 | $16.00 | 27,100 | |
| $17.15 | -1.08 | -5.9% | $19.25 | $19.92 | $16.37 | 60,900 | |
| $18.23 | -1.83 | -9.1% | $19.86 | $21.00 | $18.05 | 55,500 | |
| $20.06 | -2.73 | -12.0% | $23.61 | $24.24 | $19.73 | 94,600 | |
| $22.79 | -1.53 | -6.3% | $23.97 | $24.40 | $21.81 | 79,200 | |
| $24.32 | +2.32 | +10.5% | $21.83 | $25.14 | $20.98 | 137,900 | |
| $22.00 | -0.73 | -3.2% | $22.73 | $24.63 | $20.64 | 136,100 | |
| $22.73 | -1.47 | -6.1% | $23.72 | $24.36 | $22.08 | 46,900 | |
| $24.20 | -2.66 | -9.9% | $26.11 | $26.11 | $22.71 | 96,100 | |
| $26.86 | +0.29 | +1.1% | $26.42 | $27.90 | $26.00 | 53,400 | |
| $26.57 | -2.93 | -9.9% | $28.93 | $28.93 | $24.06 | 164,800 | |
| $29.50 | -3.00 | -9.2% | $31.59 | $33.82 | $28.30 | 244,900 | |
| $32.50 | -1.63 | -4.8% | $34.47 | $38.41 | $31.50 | 507,500 | |
| $34.13 | +0.74 | +2.2% | $33.63 | $36.00 | $33.63 | 209,800 | |
| $33.39 | +1.18 | +3.7% | $32.48 | $35.00 | $32.01 | 97,600 | |
| $32.21 | -0.21 | -0.6% | $32.53 | $32.98 | $31.72 | 149,900 | |
| $32.42 | -0.29 | -0.9% | $32.77 | $34.13 | $31.99 | 106,200 | |
| $32.71 | +2.85 | +9.5% | $29.57 | $33.00 | $29.57 | 98,300 | |
| $29.86 | +0.06 | +0.2% | $28.93 | $31.76 | $28.55 | 117,200 | |
| $29.80 | -2.20 | -6.9% | $31.64 | $33.75 | $29.71 | 191,200 | |
| $32.00 | +0.27 | +0.9% | $31.64 | $34.00 | $30.10 | 150,100 | |
| $31.73 | -0.42 | -1.3% | $32.12 | $34.00 | $31.63 | 89,600 | |
| $32.15 | +0.05 | +0.2% | $32.01 | $33.98 | $31.00 | 76,300 | |
| $32.10 | -1.03 | -3.1% | $32.90 | $34.19 | $32.10 | 230,000 | |
| $33.13 | -0.87 | -2.6% | $33.32 | $34.19 | $31.90 | 338,700 | |
| $34.00 | +0.04 | +0.1% | $34.61 | $34.61 | $32.46 | 26,000 | |
| $33.96 | +0.33 | +1.0% | $33.38 | $34.00 | $28.97 | 38,200 | |
| $33.63 | +0.75 | +2.3% | $32.22 | $34.00 | $27.37 | 135,900 | |
| $32.88 | +1.35 | +4.3% | $31.88 | $35.00 | $28.20 | 266,600 | |
| $31.53 | +0.80 | +2.6% | $31.04 | $35.50 | $30.80 | 136,322 | |
| $30.73 | +1.21 | +4.1% | $29.34 | $35.00 | $26.20 | 410,190 | |
| $29.52 | +5.87 | +24.8% | $23.90 | $29.64 | $23.58 | 428,200 | |
| $23.65 | +0.49 | +2.1% | $23.09 | $24.31 | $20.68 | 125,500 |
- Ticker
- NASDAQ:VOGX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 19, 2026
Vogenx Set to Join the Russell 2000(R), Russell 3000(R), and Russell Microcap(R) Indexes
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 22 slides
Latest news
Vogenx Set to Join the Russell 2000(R), Russell 3000(R), and Russell Microcap(R) Indexes
Nov 19, 2026
Closed $11.87 (-3.8%) on Nov 20, 2026
Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Nov 6, 2026
Closed $17.45 (-4.3%) on Nov 6, 2026
Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia
Oct 15, 2026
Closed $14.53 (-9.5%) on Oct 16, 2026
Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
Oct 9, 2026
Closed $17.56 (+0.4%) on Oct 9, 2026
Vogenx Announces Closing of Initial Public Offering
Aug 13, 2026
Closed $14.78 (+4.9%) on Aug 14, 2026
Vogenx Inc on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 5 in the last 12 months · 5 in all · newest Nov 19, 2026 · oldest 2026
- Decks
- 2 decks · latest October 2026
Where Vogenx Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VOGX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:VOGX | BOATS | United States | USD |
Valuation
Price/book 2.1× against a median of 1.7×: 8th lowest of 11 Biotechnology companies shown. balance Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $94.21M USD
- P/E
- Not reported
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 2.1×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P 500
- Under 6 months of closes
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Vogenx Inc · NASDAQ:VOGX | US$176.3M | US$94.21M | n/a | n/a | n/a | 2.1× | n/a | 0.0× | n/a |
| Antengene Corporation Limited · HKEX:6996 | US$183.1M | US$107.1M | n/a | 6.8× | n/a | 1.3× | −227.0% | 0.3× | n/a |
| Whitehawk Therapeutics, Inc. · NASDAQ:WHWK | US$181.2M | US$11.70M | n/a | n/a | n/a | 1.1× | n/a | 0.0× | 1.35 |
| Sol-Gel Technologies Ltd. · NASDAQ:SLGL | US$180.6M | US$137.0M | n/a | 95.4× | n/a | 4.2× | n/a | 0.0× | 0.67 |
| Tanvex BioPharma, Inc. · TWSE:6541 | US$180.5M | US$225.7M | n/a | 11.3× | n/a | 1.2× | −222.8% | 0.4× | n/a |
| Korro Bio, Inc. · NASDAQ:KRRO | US$179.4M | US$74.36M | n/a | 57.6× | n/a | 2.0× | n/a | 0.0× | 1.46 |
| MediWound Ltd. · NASDAQ:MDWD | US$175.5M | US$155.9M | n/a | 15.6× | n/a | 5.5× | −235.0% | 0.3× | 0.64 |
| Nanexa AB · OMXSTO:NANEXA | US$175.1M | US$170.1M | n/a | 51.4× | n/a | 13.5× | −72.5% | 0.0× | n/a |
| Compugen Ltd. · NASDAQ:CGEN | US$174.3M | US$59.55M | 4.8× | 0.8× | n/a | 2.1× | 47.9% | 0.0× | 1.49 |
| Guangzhou Innogen Pharmaceutical Group Co Ltd Class H · HKEX:2591 | US$170.8M | US$40.21M | n/a | 2.1× | n/a | 1.2× | −259.6% | 0.2× | n/a |
| Entrada Therapeutics, Inc. · NASDAQ:TRDA | US$170.3M | US$24.60M | n/a | 6.2× | n/a | 0.9× | n/a | 0.2× | 1.43 |
| Median of the others | US$177.4M | US$90.75M | 4.8× | 11.3× | 1.7× | −224.9% | 0.1× | 1.39 |
Forecasts
1 strong buy · Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 55.00 USD · Analysts' mean
- EPS, year to Dec 2026
- -1.80 · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| James Green | Chief Executive Officer, Chairman of the Board |
| Steven Delmar | Chief Financial Officer |
| Tim Boris | General Counsel |
| Bentley Cheatham | Vice President of Research & Development |
| William Wilkison | Chief Scientific Officer, Chair of the Scientific Advisory Board |
Board
| Director | Role |
|---|---|
| James Green | Chief Executive Officer, Chairman of the Board |
| William Wilkison | Chief Scientific Officer, Chair of the Scientific Advisory Board |
| Peter Pieraccini | Board Member |
| Richard Gorman | Board Member |
| Steven Delmar | Chief Financial Officer |
| Tim Boris | General Counsel |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 6, 2026 · Before open | −4.3% |
| Q2 2026 | Sep 17, 2026 | −2.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (October 2026) | Investor deck | 22 slides | October 2026 |
| IPO Roadshow | IPO roadshow | 31 slides |
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Closed: US$81.3M raised · US$13 a share · Jones Dealers: Jones (lead) | Aug 13, 2026 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$13.00 a share on Aug 11, 2026.
- Price
- US$13.00 a share
- Shares offered
- 6,250,000 shares of common stock
- Offering size
- US$81.3 million
- Underwriters' option
- Up to 937,500 more shares
- Listing
- VOGX on the Nasdaq Capital Market
- Underwriter
- Jones
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Feb 20, 2026 |
| Filed publicly | Jul 15, 2026 |
| Amended twice | Newest Aug 10, 2026 |
| Shares registered with an exchange | Aug 10, 2026 |
| Declared effective by the SEC | Aug 11, 2026 |
| Final prospectus, with the price | Aug 12, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Aug 12, 2026 |
| EFFECT · Notice that a registration is effective | Aug 11, 2026 |
| CERT · Exchange's certificate of listing | Aug 11, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Aug 10, 2026 |
| S-1/A · Registration statement, amended | Aug 10, 2026 |
| S-1/A · Registration statement, amended | Jul 29, 2026 |
| S-1 · Registration statement | Jul 15, 2026 |
| DRS/A · Draft registration statement, amended | Jun 30, 2026 |
| DRS/A · Draft registration statement, amended | Apr 2, 2026 |
| DRS · Draft registration statement | Feb 20, 2026 |
Open IPO · From the cover of the final prospectus (424B4) filed Aug 12, 2026
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 16, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 16, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 16, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 16, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 16, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 13, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 12, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 6, 2026 | Quarterly report | SEC |
All 45 filings
Cap table
Built by 6ix from Vogenx Inc’s releases · as of Sep 17, 2026
- Common shares
- 14,855,087
- Fully diluted
- 14,855,087
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 14,855,087 | Sep 17, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Sep 17, 2026 | 14,855,087 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Green Other companies: Islet Sciences Inc (CEO, Director · Oct 30, 2013 – Oct 30, 2013 · Past) | Chief Executive Officer, Chairman of the Board · Since at least Aug 11, 2026 |
| Bentley Cheatham | Vice President of Research & Development · Since at least Nov 4, 2026 |
| Kenneth John Toombs | Director · Since at least Sep 21, 2026 |
| Peter Pieraccini | Director · Since at least Aug 11, 2026 |
| Richard Gorman | Board Member · Since at least Aug 11, 2026 |
| Steven Delmar | Chief Financial Officer · Since at least Aug 13, 2026 |
| Steven R Delmar | Chief Financial Officer, Director · Since at least Aug 11, 2026 |
| Tim Boris | General Counsel · Since at least Nov 4, 2026 |
| Timothy Boris | Director · Since at least Aug 11, 2026 |
| William Wilkison | Chief Scientific Officer, Director · Since at least Aug 11, 2026 |
Log in to ask 6ix AI your own questions about Vogenx Inc.